Clinical trials
Phase 3 Diabetes Mellitus trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2025 | 6 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Active, not recruiting | 3 |
| Not yet recruiting | 3 |
| Unknown status | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 10 |
| AstraZeneca | 4 |
| Gan & Lee Pharmaceuticals. | 4 |
| Eli Lilly and Company | 3 |
| Novartis Pharmaceuticals | 2 |
| Sun Yat-sen University | 2 |
| Amgen | 1 |
| Chipscreen Biosciences, Ltd. | 1 |
| Daewoong Pharmaceutical Co. LTD. | 1 |
| Huashan Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 36 |
| Diabetes Mellitus, Type 2 | 21 |
| Endocrine System Diseases | 3 |
| Glucose Metabolism Disorders | 3 |
| Insulin Resistance | 3 |
| Metabolic Diseases | 3 |
| Confusion | 1 |
| Coronary Artery Disease | 1 |
| Diabetes Mellitus, Type 1 | 1 |
| Hyperlipidemias | 1 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.